In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system

Vaccine
Vivek BansalHarpal Singh

Abstract

Delivery of antigen through admixture formulation containing poly caprolactone (PCL) and aluminum phosphate was studied as a promising strategy to generate antigen specific immune response. The present study demonstrates the synergistic effect of admixture formulation of PCL with reduced aluminum (PCL-Al 0.2 mg-TT and PCL-PEG-Al 0.2 mg-TT) as a potential adjuvant system using tetanus toxoid (TT) as a model antigen. On evaluation of the magnitude of efficacy for the proposed formulation by ELISA as well as challenge method, persistent and strong antibody response was obtained throughout the 180 day study period on storage at 5 ± 3 °C. In comparison to the aluminum phosphate based conventional tetanus vaccine, higher levels of IFN-γ and IL-4 were obtained with PCL-Al 0.2 mg-TT and PCL-PEG-Al 0.2 mg-TT, indicating the presence of cell mediated as well as humoral immune responses. Histopathology and serum biochemistry profile in mice further indicated the suitability of the proposed formulation. Percent adsorption/encapsulation of the antigen also increased to nearly 95% in the admixture formulation compared to 55% adsorption in the conventional tetanus vaccine. The present study established a useful baseline for designing biocompa...Continue Reading

References

Feb 1, 1997·Vaccine·J C Cox, A R Coulter
Aug 20, 2002·Vaccine·Norman W BaylorPaul Richman
Aug 20, 2002·Vaccine·C J Clements, E Griffiths
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
May 14, 2005·Expert Review of Vaccines·Magnus Köping-HöggårdMaría José Alonso
Jan 31, 2006·Methods : a Companion to Methods in Enzymology·Jasvinder SinghH Oya Alpar
Dec 19, 2007·Indian Journal of Medical Microbiology·M MirsadraeeF Roknee
Aug 20, 2008·Molecular Pharmaceutics·Wenlei Jiang, Steven P Schwendeman
May 17, 2011·Current Medicinal Chemistry·L Tomljenovic, C A Shaw
Dec 4, 2013·Vaccine·Liang ZhaoAnton P J Middelberg

❮ Previous
Next ❯

Citations

Mar 5, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Pravin Shende, Mansi Waghchaure
Sep 23, 2021·Journal of Biomaterials Science. Polymer Edition·Mohammad-Amin RahmatiMehraneh Kermanian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.